Keywords
Type 2 diabetes mellitus
Epidemiological characteristics
Risk factors
Community population
Middle-aged and elderly people
Categories
How to Cite
Abstract
Objective To investigate the epidemiological characteristics and related risk factors of hypertension complicated with type 2 diabetes mellitus among community-dwelling middle-aged and elderly residents, so as to provide evidence-based references for the prevention and management of chronic comorbidities in primary public health practice. Methods A cross-sectional epidemiological study was conducted among middle-aged and elderly people in selected communities. Demographic characteristics, living habits, past medical history and related physical examination indicators were collected through questionnaire surveys and routine health examinations. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors associated with hypertension combined with type 2 diabetes. Results The prevalence of hypertension complicated with type 2 diabetes in the study population was relatively high, and the comorbid condition was closely related to age, body mass index, dyslipidemia, family history of chronic diseases, unhealthy diet, physical inactivity and other factors. Multivariate regression analysis confirmed that several variables were independent risk factors for the comorbidity of hypertension and type 2 diabetes. Conclusion The comorbidity of hypertension and type 2 diabetes is common in middle-aged and elderly community residents, and is affected by a variety of controllable and uncontrollable factors. Targeted screening, health education and comprehensive intervention measures should be strengthened in community health services to reduce the occurrence of chronic comorbidities and improve the health level of residents.
References
[1] Pascat V, Zudina L, Maurin L, et al. Partitioned polygenic scores show mechanistic heterogeneity in type 2 diabetes and hypertension comorbidity. Nat Commun. 2026;17(1):1446. doi:10.1038/s41467-025-67449-2
[2] Bulum T. Special Issue: “Recent Advances in Hypertension, Hypercholesterolemia and Type 2 Diabetes”. Biomedicines. 2026;14(1):98. doi:10.3390/biomedicines14010098
[3] Flore G, Grâce Q, Aimé FG, et al. Knowledge, opinions and experiences of researchers regarding ethical regulation of biomedical research in Benin: a cross-sectional study. BMC Med Ethics. 2022;23(1):116. doi:10.1186/s12910-022-00857-x
[4] Hirohide Y, Motoyuki Y, Supalert N, et al. An impact of dietary intervention on blood pressures among diabetic and/or hypertensive patients with high cardiovascular disorders risk in northern Thailand by cluster randomized trial. J Gen Fam Med. 2020;22(1):28–37. doi:10.1002/jgf2.379
[5] Nizal S, Shahla S, BF K. Identifying Research Gaps in the Diagnosis and Treatment of Hypertension: Evidence from a Guideline Update. Iran J Nurs Midwifery Res. 2025;30(5):771–774. doi:10.4103/ijnmr.ijnmr_274_24
[6] Fang J, Goodman SM, Wizentier MM, et al. Three Underused Statistical Methods in Social Epidemiology: Multiple Informant Models, Fractional Regression, and Restricted Mean Survival Time. Am J Epidemiol. 2025;194(11):3140–3147. doi:10.1093/aje/kwae480
[7] Diggikar MP, Janani R, Jagirdar A, et al. A Rare Presentation of Chronic Nonsteroidal Anti-inflammatory Drug-induced Acute-on-chronic Kidney Disease with Secondary Hyperaldosteronism and Hyperparathyroidism in a Young Male with Refractory Hypertension. Ann Afr Med. 2026. doi:10.4103/aam.aam_401_25
[8] Rahat ITM, Sumi ASM, Nurejannath M, et al. Identification of bacterial key genes and therapeutic targets in hypertensive patients with type 2 diabetes through bioinformatics analysis. Sci Rep. 2026;16. doi:10.1038/s41598-026-36467-5
[9] Makarem N, Yuan Y, Rousan AT, et al. Response to Comment on Yuan et al. Associations of Concurrent Hypertension and Type 2 Diabetes With Mortality Outcomes: A Prospective Study of U.S. Adults. Diabetes Care 48:1241–1250. Diabetes Care. 2026;49(2):e31–e32. doi:10.2337/dci25-0120
[10] Jo Y, Park S, Kim S, et al. National trends in the unmet healthcare needs among patients with hypertension or type 2 diabetes mellitus in Korea from 2009 to 2023. Sci Rep. 2025;16(1):534. doi:10.1038/s41598-025-29988-y
[11] Bendiab TN. Left Atrium Function Predictive Marker of Coronary Artery Disease in Hypertensive Type 2 Diabetic Subjects. Endocr Pract. 2025;31(12 Suppl):S3. doi:10.1016/j.eprac.2025.09.135
[12] Oshaju H, Chori B, Reng MR, et al. Prevalence and determinants of masked hypertension among patients with type 2 diabetes mellitus. J Hum Hypertens. 2025;39(12):1–7. doi:10.1038/s41371-025-01084-8
[13] Ararame GG, Garoma O. Determinants of medication suboptimization among patients with comorbid type 2 diabetes and hypertension in a tertiary hospital, Southwest Oromia, Ethiopia. Discov Endocrinol Metab. 2025;1(1):11. doi:10.1007/s44417-025-00011-2
[14] Zhao Y, Li H, Zhang C, et al. Association of PM2.5 with hypertension, type 2 diabetes, and multimorbidity: evidence from the China Migrants Dynamic Survey of 165,075 individuals. Int J Environ Health Res. 2025:1–14. doi:10.1080/09603123.2025.2562028
[15] Basil B, Mohammed AJ, Mba NI. Hypertension in type 2 diabetes mellitus: prevalence, patterns, determinants and implications for cardiovascular risk prediction in a population of Nigerian patients. Cardiovasc Diabetol Endocrinol Rep. 2025;11(1):23. doi:10.1186/s40842-025-00225-9
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Frontiers in Preventive Medicine